Inhibitory effect of ginsenoside Rb1 on cardiac hypertrophy induced by monocrotaline in rat

Journal of Ethnopharmacology

Volumn 111, Issue 3, 2007, Pages 567-572

  Jiang, Qing Song ^a   Huang, Xie Nan ^b   Dai, Zhi Kai ^b   Yang, Gui Zhong ^b   Zhou, Qi Xin ^a   Shi, Jing Shan ^b   Wu, Qin ^b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b ZUNYI MEDICAL UNIVERSITY   (China)

Author keywords

Calcineurin; Cardiac hypertrophy; Ginsenosides Rb1; Monocrotaline

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CALCINEURIN; GINSENOSIDE RB 1; MESSENGER RNA; MONOCROTALINE; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NFAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; DRUG STRUCTURE; ELECTRON MICROSCOPY; HEART MUSCLE CELL; HEART RIGHT VENTRICLE HYPERTROPHY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ATRIAL NATRIURETIC FACTOR; BLOTTING, WESTERN; CALCINEURIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; GENE EXPRESSION REGULATION; GINSENOSIDES; HYPERTROPHY, RIGHT VENTRICULAR; MALE; MONOCROTALINE; MYOCYTES, CARDIAC; PANAX; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION;

ANIMALIA; PANAX GINSENG; RATTUS;

EID: 34247367246     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2007.01.006     Document Type: Article

References (29)

1. Abassi Z., Brodsky S., Gealekman O., Rubinstein I., Hoffman A., and Winaver J. Intrarenal expression and distribution of cyclooxygenase isoforms in rats with experimental heart failure. American Journal of Physiology. Renal Physiology 280 (2001) F43-F53
2. Ahn B.H., Park H.K., Cho H.G., Lee H.A., Lee Y.M., Yang E.K., et al. Estrogen and enalapril attenuate the development of right ventricular hypertrophy induced by monocrotaline in ovariectomized rats. Journal of Korean Medical Science 18 (2003) 641-648
3. Blumenthal M. Asian ginseng: potential therapeutic uses. Advances in Nurse Practice 9 (2001) 26-28, 33
4. Bueno O.F., vanRooij E., Molkentin J.D., Doevendans P.A., and DeWindt L.J. Calcineurin and hypertrophic heart disease: novel in sights and remaining questions. Cardiovascular Research 53 (2002) 806-821
5. + exchange inhibitor cariporide. The Journal of Pharmacology and Experimental Therapeutics 298 (2001) 469-476
6. Chen X. Cardiovascular protection by ginsenosides and their nitric oxide releasing action. Clinical and Experimental Pharmacology and Physiology 23 (1996) 728-732
7. 2+, calcineurin, and NFAT. Cell 96 (1999) 611-614
8. 2-terminal kinase activation in the heart, cross-talk between cardiac hypertrophic signaling pathways. The Journal of Biological Chemistry 275 (2000) 13571-13579
9. Fiedler B., Lohmann S.M., Smolenski A., Linnemuller S., Pieske B., Schroder F., et al. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes. Proceedings of the National Academy of Sciences of the United States of America 99 (2002) 11363-11368
10. 2+-calcineurin-NFAT cascade in cardiac myocytes. Cardiovascular Research 63 (2004) 450-457
11. Gillis C.N. Panax ginseng pharmacology: a nitric oxide link?. Biochemical Pharmacology 54 (1997) 1-8
12. Hogan P.G., Chen L., Nardone J., and Rao H. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes and Development 17 (2003) 2205-2232
13. Hunter J.J., and Chien K.R. Signaling pathways for cardiac hypertrophy and failure. The New England Journal of Medicine 341 (1999) 1276-1283
14. 1 on lung ischemia-reperfusioninjury. The Chinese Journal of Clinical Thoracic Cardiovascular Surgery (China) 4 (1997) 151-154
15. 1 on ischemic brain injury in rat. The Journal of Apoplexy and Nervous Diseases (China) 20 (2003) 415-417
16. 2+. Acta Pharmacologica Sinica (China) 31 (1996) 321-326
17. Kempf T., and Wollert K.C. Nitric oxide and the enigma of cardiac hypertrophy. Bioessays 26 (2004) 608-615
18. 1 on synaptosomal free calcium level, ATPase and calmodulin in rat hippocampus. Chinese Medical Journal 108 (1995) 544-547
19. 1 and Re on cardiomyocyte apoptosis after ischemia and reperfusion in rats. Chinese Journal of Histochemistry and Cytochemistry (China) 11 (2002) 374-377
20. Molkentin J.D., and Dorn III G. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annual Review of Physiology 63 (2001) 391-426
21. Radad K., Gille G., Liu L., and Rausch W.D. Use of ginseng in medicine with emphasis on neurodegenerative disorders. Journal of Pharmacological Sciences 100 (2006) 175-186
22. 1 and Re decrease cardiac contraction in adult rat ventricular myocytes: role of nitric oxide. British Journal of Pharmacology 134 (2001) 1159-1165
23. Sugden P.H. Signaling pathways in cardiac myocyte hypertrophy. Annals of Medicine 33 (2001) 611-622
24. Taigen T., De Windt L.J., and Molkentin J.D. Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy. Proceedings of the National Academy of Sciences of the United States of America 97 (2000) 1196-1201
25. Vega R.B., Bassel-Duby R., and Olson E.N. Control of cardiac growth and function by calcineurin signaling. Journal of Biological Chemistry 278 (2003) 36981-36984
26. 1 on the aging process. Acta Academic Medicne Journal of Kunming (China) 21 (2000) 63-65
27. Zhang R., Crump J., and Reisin E. Regression of left ventricular hypertrophy is a key goal of hypertension management. Current Hypertension Reports 5 (2003) 301-308
28. Zhang W. Old and new tools to dissect calcineurin's role in pressure-overload cardiac hype0rtrophy. Cardiovascular Research 53 (2002) 294-303
29. Zhang W.J., Zhong G.G., Jiang Y., Wang X.M., and Wang Z.F. Single channel analysis on calcium channel blocked action of panaxadiol and panaxatriol saponins on cultured rat ventricular myocytes. Acta Pharmacologica Sinica (China) 15 (1994) 173-176